menu
Mobile
Careers
not found

Meet Alexandra

Sharing diverse, remarkable, and inspiring real-life stories is what the I am OneBlood movement is all about.

Read the Story
2025-IAOB-Q2-Alexandra-FBIG-6.jpg

Host a Blood Drive

Become an agent of change and host a blood drive.

Learn More
chair person receiving materials

Our Service Area

We are committed to saving lives in your community.

Learn More
Hands holding mobile phone on blurred city as background

Earn Rewards

You get rewarded every time you donate with OneBlood.

Learn More
Maximize you rewards logo with confetti background

Licensed High Titer COVID-19 Convalescent Plasma (CCP)

Order Form

OneBlood Receives FDA Approval

OneBlood has become the first blood center in the country to be granted full FDA approval to provide licensed high titer plasma from people who have recovered from COVID-19 for use in individuals who are immunocompromised and unable to make their own antibodies to the virus. Read the full press release.

What You Need to Know About Licensed High Titer COVID-19 Convalescent Plasma (CCP)

You can now place an order for licensed high titer CCP by filling out the form below.

You can access the ISBT product codes for licensed high titer CCP.

The Circular of Information for the product can be accessed here.

FDA communication regarding the OneBlood CCP and other reference literature can be reviewed by accessing here

OneBlood provides O, A and B high titer COVID-19 convalescent plasma.

FDA licensed high titer CCP is available in OneBlood’s inventory and is available for hospitals to order.

 

Licensed High Titer COVID-19 Convalescent Plasma Order Form

Fill out the form below and a OneBlood representative will be in touch shortly!
*All fields are required

Required

Required

Required

Please enter a valid phone number.

Required

Please enter a valid e-mail.

Required

Please enter a valid e-mail.

Required

Please enter a valid e-mail.

Is Billing the same as shipping?

Required

Please enter a valid e-mail.

This field is required.

This field is required.

This field is required.

Required

Please enter a valid e-mail.

If preferred blood type is unavailable, substitute for any type?

This field is required.

Reference Literature:

Whole Blood and blood components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived) and Apheresis Convalescent Plasma, High Titer, Anti-SARS-CoV-2)

Whole Blood and blood components (Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived) and Apheresis Convalescent Plasma, High Titer, Anti-SARS-CoV-2) | FDA

 

Latest studies regarding the benefits of COVID 19 Convalescent Plasma:

Immunocompromised RCT

Hoffmann, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5014147

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild 1 COVID-19: an international, randomised, open-label trial

http://dx.doi.org/10.2139/ssrn.5014147

 

Immunocompromised matched controls

Dequidt, Int J Infect Dis. 2024 Dec 4;151:107323

Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or

neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study

https://pubmed.ncbi.nlm.nih.gov/39643155/

Close